Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCSA Processa Pharmaceuticals, Inc.

交易中 05-06 14:59:45 EDT

0.2794

+0.0332

+13.48%

最高0.2899	最低0.2401	成交量349.87万
今开0.2450	昨收0.2462	日振幅20.23%
总市值147.22万	流通市值128.23万	总股本526.92万
成交额93.91万	换手率76.23%	流通股本458.94万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCSA","market":"US","secType":"STK","nameCN":"Processa Pharmaceuticals, Inc.","latestPrice":0.2794,"timestamp":1746557964556,"preClose":0.2462,"halted":0,"volume":3498713,"delay":0,"floatShares":4589407,"shares":5269240,"eps":-3.872706,"marketStatus":"交易中","change":0.0332,"latestTime":"05-06 14:59:45 EDT","open":0.245,"high":0.2899,"low":0.2401,"amount":939122.0943609001,"amplitude":0.202275,"askPrice":0.2799,"askSize":1600,"bidPrice":0.2754,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-3.872706,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746561600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2462,"preHourTrading":{"tag":"盘前","latestPrice":0.24,"preClose":0.2462,"latestTime":"09:27 EDT","volume":58178,"amount":14317.80476876,"timestamp":1746538027461},"postHourTrading":{"tag":"盘后","latestPrice":0.257,"preClose":0.2462,"latestTime":"19:58 EDT","volume":182866,"amount":46542.135674,"timestamp":1746489523239},"volumeRatio":1.131839},"requestUrl":"/m/hq/s/PCSA","defaultTab":"news","newsList":[{"id":"2532582805","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532582805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532582805?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:31","pubTimestamp":1746192709,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时31分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.64%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。其相关个股中，Polyrizon Ltd.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Adaptive Biotechnologies Corporation涨幅较大，Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为202.80%、149.22%、56.66%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Polyrizon Ltd.、Adaptive Biotechnologies Corporation，振幅分别为67.34%、34.37%、18.34%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213149a47003a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213149a47003a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2532005665","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅跳水6.90%报0.240美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532005665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532005665?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:32","pubTimestamp":1746106379,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时32分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅跳水6.90%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。其相关个股中，Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Kalaris Therapeutics, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Transcode Therapeutics, Inc.较为活跃，换手率分别为29.08%、14.84%、12.85%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Abpro Holdings, Inc，振幅分别为21.18%、14.25%、11.73%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213259a6d011c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213259a6d011c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2531051125","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.27%报0.217美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531051125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531051125?lang=zh_cn&edition=full","pubTime":"2025-04-30 22:48","pubTimestamp":1746024533,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日22时48分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.27%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nutriband Inc C/Wts 涨幅较大，Purple Biotech Ltd、Regulus Therapeutics Inc.、Onconetix, Inc.较为活跃，换手率分别为143.88%、30.17%、19.23%，振幅较大的相关个股有Nutriband Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为29.23%、28.00%、25.11%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430224853a6cef89e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430224853a6cef89e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2531475372","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.82%报0.222美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531475372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531475372?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:57","pubTimestamp":1745935041,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时57分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.82%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.40%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为141.15%、58.75%、23.12%，振幅较大的相关个股有Spruce Biosciences, Inc.、Cyclacel Pharmaceuticals, Inc.、Ibio, Inc.，振幅分别为31.68%、26.68%、26.67%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215722a46c4616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215722a46c4616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2529684931","title":"Processa Pharmaceuticals, Inc.盘中异动 急速下挫10.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529684931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529684931?lang=zh_cn&edition=full","pubTime":"2025-04-24 21:31","pubTimestamp":1745501485,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日21时31分，Processa Pharmaceuticals, Inc.股票出现异动，股价急速下跌10.12%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424213125a4656eca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424213125a4656eca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2529538222","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨5.32%报0.232美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529538222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529538222?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:04","pubTimestamp":1745334268,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日23时04分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.32%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042223042994de4ab1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042223042994de4ab1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2529021858","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅下挫10.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529021858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529021858?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:31","pubTimestamp":1745242293,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时31分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速下挫10.91%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Aptevo Therapeutics Inc.、Evogene Ltd.、Transcode Therapeutics, Inc.较为活跃，换手率分别为531.67%、180.43%、114.24%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Xenon制药、Naya Biosciences, Inc.，振幅分别为9.86%、7.41%、7.29%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213133a6c2707c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213133a6c2707c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2528743444","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528743444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528743444?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:41","pubTimestamp":1744897289,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时41分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.12%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为413.68%、147.17%、50.07%，振幅较大的相关个股有Channel Therapeutics Corporation、Celularity Inc.、Pulmatrix, Inc.，振幅分别为35.06%、16.94%、16.32%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417214129973b541e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417214129973b541e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2527240996","title":"Processa Pharmaceuticals, Inc.盘中异动 快速下挫6.29%报0.253美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527240996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527240996?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:33","pubTimestamp":1744810385,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时33分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.29%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029、天演药业涨幅较大，Briacell Therapeutics Corp.、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为367.23%、145.57%、17.53%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、天演药业、Prokidney Corp.，振幅分别为20.00%、20.00%、11.21%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213305a45b2dc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213305a45b2dc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2527449916","title":"Processa Pharmaceuticals, Inc.盘中异动涨5.57% 振幅达9.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527449916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527449916?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:53","pubTimestamp":1744728808,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时53分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.57%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Skye Bioscience, Inc.涨幅较大，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃，换手率分别为971.91%、481.37%、233.29%，振幅较大的相关个股有Skye Bioscience, Inc.、Dogwood Therapeutics, Inc.、Mural Oncology Plc，振幅分别为171.53%、91.33%、86.41%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152253289738ba40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152253289738ba40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2527405191","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527405191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527405191?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:31","pubTimestamp":1744637474,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时31分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅上涨7.27%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Theratechnologies Inc.涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为273.33%、128.10%、86.14%，振幅较大的相关个股有Armata Pharmaceuticals, Inc.、Proqr Therapeutics N.V.、Artelo Biosciences, Inc.，振幅分别为12.50%、9.32%、7.30%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213114a6ba1bd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213114a6ba1bd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2518274630","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.74%报0.515美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518274630?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613578,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅上涨6.74%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2042.36%、403.78%、59.56%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为99.91%、99.13%、98.72%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213258a26a251e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213258a26a251e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2517192858","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517192858?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:39","pubTimestamp":1741289990,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时39分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速跳水7.66%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033951abebc101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033951abebc101&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2516038626","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516038626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516038626?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:26","pubTimestamp":1741101968,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时26分，Processa Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.80%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232608abe7ffc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232608abe7ffc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2516634054","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅下挫5.26%报0.520美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634054?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:44","pubTimestamp":1741013066,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时44分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.26%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Aldeyra Therapeutics, Inc.、Geovax Labs, Inc.涨幅较大，Entero Therapeutics Inc.、Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为99.60%、52.65%、43.38%，振幅较大的相关个股有Entero Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为55.45%、24.83%、22.27%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224426989a1333&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224426989a1333&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2514633316","title":"Processa Pharmaceuticals, Inc.盘中异动 急速跳水5.67%报0.516美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514633316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514633316?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:23","pubTimestamp":1740677027,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时23分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.67%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Pepgen Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Ibio, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1719.86%、295.31%、124.40%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd，振幅分别为86.14%、50.65%、47.79%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801234798953193&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801234798953193&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2514166350","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514166350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514166350?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:39","pubTimestamp":1740497961,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时39分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.23%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1085.21%、1053.80%、602.38%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为224.93%、64.05%、61.16%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523392198925bb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523392198925bb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2513778982","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.55%报0.559美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778982?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:10","pubTimestamp":1740409852,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时10分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.55%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为173.39%、74.39%、26.10%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231052abdb176f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231052abdb176f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2513329667","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅上涨7.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513329667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513329667?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:35","pubTimestamp":1740148554,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时35分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速上涨7.25%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为72.73%、65.34%、16.78%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.，振幅分别为33.83%、30.00%、25.39%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223554962b7c50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223554962b7c50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2512335435","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.72%报0.565美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512335435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512335435?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:57","pubTimestamp":1739991478,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时57分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.72%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为670.86%、254.32%、228.87%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为267.43%、159.49%、65.50%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200257599628f7ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200257599628f7ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.processapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0.0463},{"period":"1month","weight":-0.2759},{"period":"3month","weight":-0.6104},{"period":"6month","weight":-0.7802},{"period":"1year","weight":-0.8865},{"period":"ytd","weight":-0.7214}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.1152},{"period":"3month","weight":-0.0636},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.1021},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司，致力于药物产品的开发，该产品旨在为高度未满足的患者提供治疗方法并改善其生存率和生活质量。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.248045},{"month":2,"riseRate":0.571429,"avgChangeRate":0.073235},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.127227},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.105856},{"month":5,"riseRate":0.25,"avgChangeRate":-0.089394},{"month":6,"riseRate":0.714286,"avgChangeRate":0.170494},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.109157},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.10415},{"month":9,"riseRate":0.571429,"avgChangeRate":0.100987},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.118178},{"month":11,"riseRate":0.428571,"avgChangeRate":0.093414},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.169338}],"exchange":"NASDAQ","name":"Processa Pharmaceuticals, Inc.","nameEN":"Processa Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Processa Pharmaceuticals, Inc.,PCSA,Processa Pharmaceuticals, Inc.股票,Processa Pharmaceuticals, Inc.股票老虎,Processa Pharmaceuticals, Inc.股票老虎国际,Processa Pharmaceuticals, Inc.行情,Processa Pharmaceuticals, Inc.股票行情,Processa Pharmaceuticals, Inc.股价,Processa Pharmaceuticals, Inc.股市,Processa Pharmaceuticals, Inc.股票价格,Processa Pharmaceuticals, Inc.股票交易,Processa Pharmaceuticals, Inc.股票购买,Processa Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}